Gyre Therapeutics, Inc. GYRE EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s EPS (basic)?
- Gyre Therapeutics, Inc. (GYRE) reported EPS (basic) of -$0.10 in Q1 2026.
- How has Gyre Therapeutics, Inc.'s EPS (basic) changed year-over-year?
- Gyre Therapeutics, Inc.'s EPS (basic) decreased by 433.3% year-over-year, from $0.03 to -$0.10.
- What is the long-term trend for Gyre Therapeutics, Inc.'s EPS (basic)?
- Over 2 years (2021 to 2024), Gyre Therapeutics, Inc.'s EPS (basic) has grown at a -77.9% compound annual growth rate (CAGR), from -$2.87 to $0.14.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.